Mucus

Infectious Coryza is a bacterial disease that affects upper respiratory tract of chicken and manifest itself with closed eyes, discharges from nostrils and death. This is the culprit responsible for high mortality mostly seen in chicks. It is not the only disease that affects eyes but it is a killer disease and most chicken farms are suffering from it in Namibia.  Poultry being a niche inteprise it is upon that fact that farmers be given information. This bacteria affects other birds like quails and pheasants as well. Therefore poultry farmers need to know signs of Infectious Coryza in order to control its incidences on farms. All birds act as reservoirs and all ages are susceptible. It takes about 1-3 days from infection to the first clinical sign appearance and the disease situation takes about 2-3 weeks. The disease can affect 70% of the population especially if birds are kept in poorly ventilated houses. Despite this disease being deadly and affecting all chicken age group

IPC training UNICEF conducted training on IPC protocols and measures to total of 183 staff including 54 staff (12 males, 52 females) from the health facilities in six municipalities of greaterTripoli; 14 staff( 7 males, 7 females) from Ministry of Environment; 15 staff( 07 males, 08 females) from the Ministry of Water Resources. Additionally UNICEF organized Infection Prevention and Control (IPC) training targeting health workers in isolation and triage centers in the south region, 100 persons (73 women: 27 men) mainly health care workers benefitted from the training in the municipalities of Wadi Aitba, Algurayfa, Tragain, Adry Alshate and Ubari. Critical topics related to hygiene and Covid-19 were covered in these sessions including principles and practices of hand hygiene in community and health care settings with a mini work shop on the same, social distancing and sneezing and coughing etiquette, PPEs and detailed discussion and training on masks, and discussions on IPC

Department of Neurosurgery, Tulane Center for Clinical Neurosciences, Tulane University School of Medicine, New Orleans, LA, USA Department of Neurology, Tulane Center for Clinical Neurosciences, Tulane University School of Medicine, New Orleans, LA, USA Department of Anatomical Sciences, St. George's University, St. George's, Grenada Department of Structural & Cellular Biology, Tulane University School of Medicine, New Orleans, LA, USA Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA Department of Neurosurgery and Ochsner Neuroscience Institute, Ochsner Health System, New Orleans, LA, USA University of Queensland, Brisbane, Australia Search for more papers by this author Adblock test (Why?)

Key Takeaways In a new paper, researchers are warning pregnant people not to take acetaminophen, a common over-the-counter (OTC) medication used to treat pain and relieve fevers. The researchers cite some previous research that linked acetaminophen use in pregnancy to negative health outcomes in babies and children. Doctors say that pregnant people should be cautious about taking any medications, including acetaminophen. For years, acetaminophen (also called paracetamol) has been considered a safe medication to take for pain relief during pregnancy. Now, researchers warn that the common over-the-counter (OTC) pain reliever may interfere with fetal development, and they are advising pregnant people to be cautious about taking the drug. Tylenol is a popular brand of acetaminophen. New Recommendations In the new consensus statement published in Nature Reviews Endocrinology, the researchers cite a growing body of evidence that suggests acetaminoph

As COVID-19 cases continue to skyrocket across the U.S. and the world, few options are available for treating patients infected with the SARS-CoV-2. But new research from the University of Georgia offers hope for a viable therapeutic to combat the disease that has claimed more than 4 million lives worldwide. Published in Nature's Scientific Reports, the study found that probenecid has broad antiviral properties, making it a prime candidate to combat not only SARS-CoV-2 infection but also other common and deadly respiratory viruses like RSV and flu. Probenecid is an FDA-approved medication that's primarily used to treat gout, and it's already widely available in the U.S. The drug has been on the market for over 40 years and has minimal side effects. Ralph Tripp, GRA Eminent Scholar of Vaccine and Therapeutic Studies, talks with a colleague. (Photo by Peter Frey/UGA) "There's really nothing out there to safely fight these viruses," said Ralph Tripp, l

Skip to content Top Navigation Close this dialog window Explore Health.com Profile Menu Close Sign in Close this dialog window View image Illinois Man Dies of Rabies After Waking Up With a Bat on His Neck—What to Know About This Infectious Disease this link is to an external site that may or may not meet accessibility guidelines.